Methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1S)-2-(4-chloropyrazol-1-yl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(5-chloro-2-pyridinyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1R)-2-(4,4-difluorocyclohexyl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(4,4-difluorocyclohexyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate
C110H139Cl2F4N15O16 — CID 159986049
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1S)-2-(4-chloropyrazol-1-yl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(5-chloro-2-pyridinyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1R)-2-(4,4-difluorocyclohexyl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(4,4-difluorocyclohexyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate
Methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1S)-2-(4-chloropyrazol-1-yl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(5-chloro-2-pyridinyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1R)-2-(4,4-difluorocyclohexyl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(4,4-difluorocyclohexyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate (PubChem CID 159986049) has the molecular formula C110H139Cl2F4N15O16 and a molecular weight of 2074.31 g/mol. Its IUPAC name is methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1S)-2-(4-chloropyrazol-1-yl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(5-chloro-2-pyridinyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1R)-2-(4,4-difluorocyclohexyl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(4,4-difluorocyclohexyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate.
Molecular Properties
| Compound Name | Methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1S)-2-(4-chloropyrazol-1-yl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(5-chloro-2-pyridinyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1R)-2-(4,4-difluorocyclohexyl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(4,4-difluorocyclohexyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate |
|---|---|
| PubChem CID | 159986049 |
| Molecular Formula | C110H139Cl2F4N15O16 |
| Molecular Weight | 2074.31 g/mol |
| Exact Mass | 2071.98 |
| IUPAC Name | methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1S)-2-(4-chloropyrazol-1-yl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(5-chloro-2-pyridinyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(1R)-2-(4,4-difluorocyclohexyl)-1-hydroxyethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate;methyl (7S)-3-[(1R,3R)-3-acetylcyclohexyl]-2-[(R)-(4,4-difluorocyclohexyl)-hydroxymethyl]-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinoline-6-carboxylate |
| SMILES | COC(=O)N1c2ccc3c(nc([C@@H](O)Cn4cc(Cl)cn4)n3[C@@H]3CCC[C@@H](C(C)=O)C3)c2CC[C@@H]1C.COC(=O)N1c2ccc3c(nc([C@H](O)C4CCC(F)(F)CC4)n3[C@@H]3CCC[C@@H](C(C)=O)C3)c2CC[C@@H]1C.COC(=O)N1c2ccc3c(nc([C@H](O)CC4CCC(F)(F)CC4)n3[C@@H]3CCC[C@@H](C(C)=O)C3)c2CC[C@@H]1C.COC(=O)N1c2ccc3c(nc([C@H](O)c4ccc(Cl)cn4)n3[C@@H]3CCC[C@@H](C(C)=O)C3)c2CC[C@@H]1C |
| InChI | InChI=1S/C29H39F2N3O4.C28H37F2N3O4.C27H31ClN4O4.C26H32ClN5O4/c1-17-7-8-22-23(33(17)28(37)38-3)9-10-24-26(22)32-27(25(36)15-19-11-13-29(30,31)14-12-19)34(24)21-6-4-5-20(16-21)18(2)35;1-16-7-8-21-22(32(16)27(36)37-3)9-10-23-24(21)31-26(25(35)18-11-13-28(29,30)14-12-18)33(23)20-6-4-5-19(15-20)17(2)34;1-15-7-9-20-22(31(15)27(35)36-3)11-12-23-24(20)30-26(25(34)21-10-8-18(28)14-29-21)32(23)19-6-4-5-17(13-19)16(2)33;1-15-7-8-20-21(31(15)26(35)36-3)9-10-22-24(20)29-25(23(34)14-30-13-18(27)12-28-30)32(22)19-6-4-5-17(11-19)16(2)33/h9-10,17,19-21,25,36H,4-8,11-16H2,1-3H3;9-10,16,18-20,25,35H,4-8,11-15H2,1-3H3;8,10-12,14-15,17,19,25,34H,4-7,9,13H2,1-3H3;9-10,12-13,15,17,19,23,34H,4-8,11,14H2,1-3H3/t17-,20+,21+,25+;16-,19+,20+,25+;15-,17+,19+,25+;15-,17+,19+,23-/m0000/s1 |
| InChIKey | OGIRHCGGACZGEU-VHUDUJSVSA-N |
| XLogP | 22.88 |
| TPSA | 369.35 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 147 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2074.31 |
| LogP ≤ 5 | 22.88 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 27 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159986049 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.